Science and R&D

In an economy powered by innovation and technology, more proactive R&D policies are key to success.

R&D funding hit hard by govt. shutdown

Innovation Trail
Stephen Ezell argues the shutdown is just another example of the failure of the federal government to consistently and predictably invest in scientific research.

Engineering 2.0: Rekindling American Ingenuity

September 11, 2013 - 9:00am - 10:30am
The Information Technology and Innovation Foundation
1101 K Street, NW
Suite 610A

Engineering is the “sine qua non” of technological innovation. Unfortunately, the U.S. is falling behind in the race for global innovation advantage in part because we are unable to efficiently translate research into competitively produced products. This leads to huge trade deficits in advanced technology products and stagnant growth. Read more »

What Emerging Knowledge Economy?

August 29, 2013
| Blogs & Op-eds

It's not uncommon for many college education and STEM advocates to claim that the fastest growing occupations over the next decade will require a college education and/or STEM skills. In this view, the economy is shedding low skill jobs (either from automation or trade) and America is specializing in high-wage, knowledge-based jobs that require a college degree.

Scientific Researchers at Asian Universities Attracting More Industry Funding than American Counterparts

August 21, 2013
| Blogs & Op-eds

A report released last week by Times Higher Education, the World Academic Summit Innovation Index, finds that university scientific researchers from many Asian nations—including Korea, Singapore, Taiwan, and China—are attracting substantially more industry funding per researcher than their American counterparts. What makes this all the more striking is that American researchers tend to cost more than their Korean counterparts, and yet the latter still receive more funding.

New Evidence in Favor of Government R&D Funding

July 23, 2013
| Blogs & Op-eds

New study summarizes years of research on federal funding for R&D; finds it beneficial.

The Pharma Industry Is One Of The Most R&D Intensive Industries In The United States.

Measured by R&D expenditures per employee, the U.S. biopharmaceutical sector leads all other U.S. manufacturing industries, investing more than ten times the amount of R&D per employee than the average U.S. manufacturing industry.

Intangible Spending Rewrites U.S. History as GDP Meets R&D

Bloomberg Businessweek
R&D will no longer be treated as a mere expense, it will be categorized on the government’s books as an investment.

Hearing on Reforming the National Lab System

July 11, 2013
| Testimony and Filings

In testimony to the U.S. House of Representatives Committee on Science, Space and Technology Subcommittee on Energy, Matthew Stepp argued that federally funded research results in scientific discovery that can play a positive role in America’s economic future. He explained that after a year of research with the labs, DOE, industry, and academia it became plainly apparent that the current system needs substantial reform. He emphasized that taxpayer resources should be used as effectively as possible and that market forces can help bring efficiency and rationality to the lab system.

Turning the Page: Reimagining the National Labs in the 21st Century Innovation Economy

June 19, 2013
| Reports

Download an excerpt: "Summary of Policy Reforms"


The National Labs are a tremendous R&D resource, but their operations are still based on a decades-old management model that no longer meets the needs of our modern innovation ecosystem. This study presents a series of concrete proposals for Congress and the Administration that can ensure the Labs better meet their mission and produce useful technologies that benefit the American economy.